HAPLN1 and Miyoshi myopathy: Our earlier studies showed that in MM cells, the PTR1 domain of HAPLN1 (HAPLN1-PTR1), when purified as a GST fusion protein, elicited an NF-κB response and drug resistance (Huynh et al, 2018).